...
首页> 外文期刊>Tissue antigens. >Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L.
【24h】

Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L.

机译:两种针对CD40L的新型单克隆抗体的表征和应用:细胞膜CD40L的表位和功能研究以及可溶性血清CD40L的起源研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract CD40 ligand, a 33-kDa cell membrane molecule, a member of the tumor necrosis factor superfamily, is an important costimulatory molecule during immune response. Here, we report on two functional mouse anti-human CD40L monoclonal antibodies 1B1 and 4F1 characterized by flow cytometry, Western blotting, and competition assay. The antibodies bound to distinct CD40L epitopes and therefore resulted in different bioactivity. Both antibodies could induce CD4(+) T-cell alloantigenic hyporesponsiveness ex vivo. The antibodies were matched to develop a two-site enzyme-linked immunosorbent assay (ELISA) for soluble CD40L (sCD40L). Using this ELISA assay, we found major differences between plasma and serum sCD40L levels. Because the count of platelet sharply decreased in aplastic anemia (AA) and idiopathic thrombocytopenic purpura (ITP), we further analyzed the sCD40L concentration in the plasma of AA and ITP patients. The results showed that the sCD40L in serum was much lower than that of healthy subjects. These data demonstrate that platelets seem to be a major contributor to sCD40L, though not the only source of sCD40L in serum.
机译:摘要CD40配体是一种33 kDa的细胞膜分子,是肿瘤坏死因子超家族的成员,是免疫应答过程中重要的共刺激分子。在这里,我们报告了两种功能小鼠抗人CD40L单克隆抗体1B1和4F1,其特征在于流式细胞仪,蛋白质印迹和竞争分析。抗体结合不同的CD40L表位,因此导致不同的生物活性。两种抗体都可以离体诱导CD4(+)T细胞同种异体抗原反应低下。匹配抗体以开发用于可溶性CD40L(sCD40L)的两点酶联免疫吸附测定(ELISA)。使用此ELISA分析,我们发现血浆和血清sCD40L水平之间存在主要差异。由于再生障碍性贫血(AA)和特发性血小板减少性紫癜(ITP)中血小板的数量急剧减少,因此我们进一步分析了AA和ITP患者血浆中sCD40L的浓度。结果表明,血清中的sCD40L远低于健康人。这些数据表明血小板似乎是sCD40L的主要贡献者,尽管不是血清中sCD40L的唯一来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号